Pharmacyclics’ Leukemia Drug Scores over Glaxo’s in Head-to-Head Trial
Pharmacyclics Inc. (PCYC:US)’s drug for chronic lymphocytic leukemia which was released this year, Imbruvica, aided the patients to live longer without the disease getting aggravated as compared to the GlaxoSmi...